Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 8/20 | 0.72 |
| ▸ | ALK | Q9UM73 | 12/20 | 0.66 |
| ▸ | INSR | P06213 | 3/20 | 0.65 |
| ▸ | IGF1R | P08069 | 3/20 | 0.65 |
| ▸ | AURKA | O14965 | 1/20 | 0.65 |
| ▸ | ROS1 | P08922 | 1/20 | 0.65 |
| ▸ | EML4 | Q9HC35 | 1/20 | 0.65 |
| ▸ | ZAP70 | P43403 | 1/20 | 0.62 |
| ▸ | MET | P08581 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29216391 | 1.00 | EGFR (0.72) | EGFRALKINSRIGF1RAURKA | |
| SCHEMBL24326974 | 0.96 | EGFR (0.74) | EGFRALKINSRIGF1RAURKA | |
| SCHEMBL26778353 | 0.89 | ALK (0.75) | EGFRALKINSRIGF1RAURKA | |
| SCHEMBL29661303 | 0.89 | ALK (0.75) | EGFRALKINSRIGF1RAURKA | |
| SCHEMBL31592456 | 0.88 | EGFR (0.56) | EGFRALKINSRIGF1RAURKA | |
| SCHEMBL24327466 | 0.88 | EGFR (0.65) | EGFRALKINSRIGF1RZAP70 | |
| SCHEMBL24327081 | 0.86 | EGFR (0.73) | EGFRALKINSRIGF1RAURKA | |
| SCHEMBL25004490 | 0.86 | EGFR (0.60) | EGFRALKINSRIGF1R | |
| SCHEMBL30223003 | 0.86 | EGFR (0.60) | EGFRALKINSRIGF1R | |
| SCHEMBL26778364 | 0.84 | ALK (0.77) | EGFRALKINSRIGF1RAURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117794914-A | Pyrimidine-2, 4-diamine derivatives, process for preparing the same, and pharmaceutical composition for preventing or treating cancer comprising the same as active ingredient | 韩国化学研究院 | 2024-03-29 | — | — | CN | claimed |
| WO-2023287130-A1 | NOVEL PYRIMIDINE-2,4-DIAMINE DERIVATIVES, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER | 한국화학연구원 | 2023-01-19 | — | — | WO | claimed |
| CN-117794914-A | Pyrimidine-2, 4-diamine derivatives, process for preparing the same, and pharmaceutical composition for preventing or treating cancer comprising the same as active ingredient | 韩国化学研究院 | 2024-03-29 | — | — | CN | disclosed |
| WO-2023287130-A1 | NOVEL PYRIMIDINE-2,4-DIAMINE DERIVATIVES, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER | 한국화학연구원 | 2023-01-19 | — | — | WO | disclosed |